NovoCure Signs Contract With Austrian Insurers

NovoCure said Tuesday it has signed a contract with the Federation of the Austrian Social Insurance Institutions, which grants reimbursement across Austria for Optune, Novocure’s Tumor Treating Fields delivery system, for the treatment of adults with newly diagnosed glioblastoma, a brain tumor.

All 18 Austrian insurance funds have agreed to participate in the contract, the company said on Tuesday. Thus us Novocure’s first national reimbursement for Optune. The shares rose 0.6% on Tuesday morning.

Leave a Comment